These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 32078764

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Novel lead structures with both Plasmodium falciparum gametocytocidal and asexual blood stage activity identified from high throughput compound screening.
    Sun W, Huang X, Li H, Tawa G, Fisher E, Tanaka TQ, Shinn P, Huang W, Williamson KC, Zheng W.
    Malar J; 2017 Apr 13; 16(1):147. PubMed ID: 28407766
    [Abstract] [Full Text] [Related]

  • 4. Antiapicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the malaria box.
    Bowman JD, Merino EF, Brooks CF, Striepen B, Carlier PR, Cassera MB.
    Antimicrob Agents Chemother; 2014 Apr 13; 58(2):811-9. PubMed ID: 24247137
    [Abstract] [Full Text] [Related]

  • 5. Luciferase-Based, High-Throughput Assay for Screening and Profiling Transmission-Blocking Compounds against Plasmodium falciparum Gametocytes.
    Lucantoni L, Fidock DA, Avery VM.
    Antimicrob Agents Chemother; 2016 Apr 13; 60(4):2097-107. PubMed ID: 26787698
    [Abstract] [Full Text] [Related]

  • 6. Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.
    Antonova-Koch Y, Meister S, Abraham M, Luth MR, Ottilie S, Lukens AK, Sakata-Kato T, Vanaerschot M, Owen E, Jado JC, Maher SP, Calla J, Plouffe D, Zhong Y, Chen K, Chaumeau V, Conway AJ, McNamara CW, Ibanez M, Gagaring K, Serrano FN, Eribez K, Taggard CM, Cheung AL, Lincoln C, Ambachew B, Rouillier M, Siegel D, Nosten F, Kyle DE, Gamo FJ, Zhou Y, Llinás M, Fidock DA, Wirth DF, Burrows J, Campo B, Winzeler EA.
    Science; 2018 Dec 07; 362(6419):. PubMed ID: 30523084
    [Abstract] [Full Text] [Related]

  • 7. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
    Bosson-Vanga H, Primas N, Franetich JF, Lavazec C, Gomez L, Ashraf K, Tefit M, Soulard V, Dereuddre-Bosquet N, Le Grand R, Donnette M, Mustière R, Amanzougaghene N, Tajeri S, Suzanne P, Malzert-Fréon A, Rault S, Vanelle P, Hutter S, Cohen A, Snounou G, Roques P, Azas N, Lagardère P, Lisowski V, Masurier N, Nguyen M, Paloque L, Benoit-Vical F, Verhaeghe P, Mazier D.
    Microbiol Spectr; 2021 Oct 31; 9(2):e0027421. PubMed ID: 34724729
    [Abstract] [Full Text] [Related]

  • 8. Progressing the global antimalarial portfolio: finding drugs which target multiple Plasmodium life stages.
    Smith PW, Diagana TT, Yeung BK.
    Parasitology; 2014 Jan 31; 141(1):66-76. PubMed ID: 23746048
    [Abstract] [Full Text] [Related]

  • 9. Identification of MMV malaria box inhibitors of plasmodium falciparum early-stage gametocytes using a luciferase-based high-throughput assay.
    Lucantoni L, Duffy S, Adjalley SH, Fidock DA, Avery VM.
    Antimicrob Agents Chemother; 2013 Dec 31; 57(12):6050-62. PubMed ID: 24060871
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit Plasmodium falciparum Parasite Proliferation.
    Sosa Y, Deniskin R, Frame IJ, Steiginga MS, Bandyopadhyay D, Graybill TL, Kallal LA, Ouellette MT, Pope AJ, Widdowson KL, Young RJ, Akabas MH.
    ACS Infect Dis; 2019 Oct 11; 5(10):1738-1753. PubMed ID: 31373203
    [Abstract] [Full Text] [Related]

  • 14. Phenotypic Screens in Antimalarial Drug Discovery.
    Hovlid ML, Winzeler EA.
    Trends Parasitol; 2016 Sep 11; 32(9):697-707. PubMed ID: 27247245
    [Abstract] [Full Text] [Related]

  • 15. A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery.
    Almela MJ, Lozano S, Lelièvre J, Colmenarejo G, Coterón JM, Rodrigues J, Gonzalez C, Herreros E.
    PLoS One; 2015 Sep 11; 10(8):e0135139. PubMed ID: 26317851
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A novel approach for the discovery of chemically diverse anti-malarial compounds targeting the Plasmodium falciparum Coenzyme A synthesis pathway.
    Fletcher S, Avery VM.
    Malar J; 2014 Aug 31; 13():343. PubMed ID: 25174342
    [Abstract] [Full Text] [Related]

  • 18. Phenotypic Screening of Small Molecules with Antimalarial Activity for Three Different Parasitic Life Stages.
    Kato N, March S, Bhatia SN, Marti M.
    Methods Mol Biol; 2018 Aug 31; 1787():41-52. PubMed ID: 29736708
    [Abstract] [Full Text] [Related]

  • 19. Multistage inhibitors of the malaria parasite: Emerging hope for chemoprotection and malaria eradication.
    Poonam, Gupta Y, Gupta N, Singh S, Wu L, Chhikara BS, Rawat M, Rathi B.
    Med Res Rev; 2018 Sep 31; 38(5):1511-1535. PubMed ID: 29372568
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.